Combating antibiotic resistance

Journal of the American Dental Association

Volumn 135, Issue 4, 2004, Pages 484-487

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFRADINE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; PENICILLIN V POTASSIUM; TETRACYCLINE;

ALLERGY; ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DENTIST; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; DRUG UTILIZATION; ENDOCARDITIS; HIGH RISK PATIENT; HUMAN; INFECTION; INFECTIOUS ARTHRITIS; MEDICAL PRACTICE; MICROFLORA; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; SIDE EFFECT; TOXICITY;

EID: 2342585271     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2004.0214     Document Type: Article

References (18)

1. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340:493-501.
2. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001;32(1):108-15.
3. Flournoy DJ. Methicillin-resistant Staphylococcus aureus at a Veterans Affairs Medical Center (1986-96). J Okla State Med Assoc 1997;90(6):228-35.
4. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D. Pneumococcus Study Group. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156:732-5.
5. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990;150:1401-5.
6. Stratton CW. Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance. Emerg Infect Dis 2003;9(1):10-6.
7. Khan K, Muennig P, Behta M, Zivin JG. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med 2002;347(23):1850-9.
8. Musoke RN, Revathi G. Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr 2000;46(2):86-91.
9. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345(18):1318-30.
10. Doern GV, Ferraro MJ, Brueggemann AB, Ruof TKL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40: 891-4.
11. Jorgensen MG, Slots J. The ins and outs of periodontal antimicrobial therapy. J Calif Dent Assoc 2002;30(4):297-305.
12. Normark BH, Normark S. Evolution and spread of antibiotic resistance. J Inter Med 2002;252(2):91-106.
13. Kozlova EV, Pivovarenko TV, Malinovskaia IV, Aminov RI, Kovalenko NK, Voronin AM. Antibiotic resistance of Lactobacillus strains [in Russian]. Antibiot Khimioter 1992;37(6):12-5.
14. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JADA 1997;128:1142-51.
15. American Dental Association; American Academy of Orthopedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. JADA 2003;134:895-9.
16. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29(supplement 3):136-59.
17. Ciancio SG, ed. ADA guide to dental therapeutics. 3rd ed. Chicago: ADA Publishing; 2003:136-72.
18. Physicians' desk reference. 58th ed. Montvale, N.J.: Medical Economics; 2004:1321.